Global Cardiovascular Drug-Eluting Stents(DES) Supply, Demand and Key Producers, 2023-2029
The global Cardiovascular Drug-Eluting Stents(DES) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report studies the global Cardiovascular Drug-Eluting Stents(DES) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiovascular Drug-Eluting Stents(DES), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular Drug-Eluting Stents(DES) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiovascular Drug-Eluting Stents(DES) total production and demand, 2018-2029, (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) total production value, 2018-2029, (USD Million)
Global Cardiovascular Drug-Eluting Stents(DES) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cardiovascular Drug-Eluting Stents(DES) domestic production, consumption, key domestic manufacturers and share
Global Cardiovascular Drug-Eluting Stents(DES) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Cardiovascular Drug-Eluting Stents(DES) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin and Terumo Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiovascular Drug-Eluting Stents(DES) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cardiovascular Drug-Eluting Stents(DES) Market, By Region:
1. How big is the global Cardiovascular Drug-Eluting Stents(DES) market?
2. What is the demand of the global Cardiovascular Drug-Eluting Stents(DES) market?
3. What is the year over year growth of the global Cardiovascular Drug-Eluting Stents(DES) market?
4. What is the production and production value of the global Cardiovascular Drug-Eluting Stents(DES) market?
5. Who are the key producers in the global Cardiovascular Drug-Eluting Stents(DES) market?
6. What are the growth factors driving the market demand?
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report studies the global Cardiovascular Drug-Eluting Stents(DES) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiovascular Drug-Eluting Stents(DES), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular Drug-Eluting Stents(DES) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiovascular Drug-Eluting Stents(DES) total production and demand, 2018-2029, (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) total production value, 2018-2029, (USD Million)
Global Cardiovascular Drug-Eluting Stents(DES) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cardiovascular Drug-Eluting Stents(DES) domestic production, consumption, key domestic manufacturers and share
Global Cardiovascular Drug-Eluting Stents(DES) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Cardiovascular Drug-Eluting Stents(DES) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin and Terumo Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiovascular Drug-Eluting Stents(DES) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cardiovascular Drug-Eluting Stents(DES) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Passive Coating
- Active Coating
- Hospital
- Clinic
- MIV Therapeutics
- Orbusneich
- Promed Medical
- Relisys Medical
- Reva Medical
- Sahajanand
- Sino Medical
- Sorin
- Terumo Medical
- Abbott Vascular
- Advantec Vascular
- B.Braun Melsengen AG
- Biosensors
- Boston Scientific
- MicroPort Medical
1. How big is the global Cardiovascular Drug-Eluting Stents(DES) market?
2. What is the demand of the global Cardiovascular Drug-Eluting Stents(DES) market?
3. What is the year over year growth of the global Cardiovascular Drug-Eluting Stents(DES) market?
4. What is the production and production value of the global Cardiovascular Drug-Eluting Stents(DES) market?
5. Who are the key producers in the global Cardiovascular Drug-Eluting Stents(DES) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cardiovascular Drug-Eluting Stents(DES) Introduction
1.2 World Cardiovascular Drug-Eluting Stents(DES) Supply & Forecast
1.2.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value (2018 & 2022 & 2029)
1.2.2 World Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.2.3 World Cardiovascular Drug-Eluting Stents(DES) Pricing Trends (2018-2029)
1.3 World Cardiovascular Drug-Eluting Stents(DES) Production by Region (Based on Production Site)
1.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018-2029)
1.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2018-2029)
1.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2029)
1.3.4 North America Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.5 Europe Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.6 China Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.7 Japan Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiovascular Drug-Eluting Stents(DES) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cardiovascular Drug-Eluting Stents(DES) Demand (2018-2029)
2.2 World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region
2.2.1 World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region (2018-2023)
2.2.2 World Cardiovascular Drug-Eluting Stents(DES) Consumption Forecast by Region (2024-2029)
2.3 United States Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.4 China Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.5 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.6 Japan Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.7 South Korea Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.8 ASEAN Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.9 India Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
3 WORLD CARDIOVASCULAR DRUG-ELUTING STENTS(DES) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Manufacturer (2018-2023)
3.2 World Cardiovascular Drug-Eluting Stents(DES) Production by Manufacturer (2018-2023)
3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023)
3.4 Cardiovascular Drug-Eluting Stents(DES) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiovascular Drug-Eluting Stents(DES) in 2022
3.5.3 Global Concentration Ratios (CR8) for Cardiovascular Drug-Eluting Stents(DES) in 2022
3.6 Cardiovascular Drug-Eluting Stents(DES) Market: Overall Company Footprint Analysis
3.6.1 Cardiovascular Drug-Eluting Stents(DES) Market: Region Footprint
3.6.2 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
3.6.3 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison
4.1.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Comparison
4.2.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison
4.3.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
4.5 China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share
4.5.1 China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.5.3 China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
4.6 Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiovascular Drug-Eluting Stents(DES) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Passive Coating
5.2.2 Active Coating
5.3 Market Segment by Type
5.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2018-2029)
5.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2018-2029)
5.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cardiovascular Drug-Eluting Stents(DES) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2018-2029)
6.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2018-2029)
6.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 MIV Therapeutics
7.1.1 MIV Therapeutics Details
7.1.2 MIV Therapeutics Major Business
7.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 MIV Therapeutics Recent Developments/Updates
7.1.6 MIV Therapeutics Competitive Strengths & Weaknesses
7.2 Orbusneich
7.2.1 Orbusneich Details
7.2.2 Orbusneich Major Business
7.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Orbusneich Recent Developments/Updates
7.2.6 Orbusneich Competitive Strengths & Weaknesses
7.3 Promed Medical
7.3.1 Promed Medical Details
7.3.2 Promed Medical Major Business
7.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Promed Medical Recent Developments/Updates
7.3.6 Promed Medical Competitive Strengths & Weaknesses
7.4 Relisys Medical
7.4.1 Relisys Medical Details
7.4.2 Relisys Medical Major Business
7.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Relisys Medical Recent Developments/Updates
7.4.6 Relisys Medical Competitive Strengths & Weaknesses
7.5 Reva Medical
7.5.1 Reva Medical Details
7.5.2 Reva Medical Major Business
7.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Reva Medical Recent Developments/Updates
7.5.6 Reva Medical Competitive Strengths & Weaknesses
7.6 Sahajanand
7.6.1 Sahajanand Details
7.6.2 Sahajanand Major Business
7.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sahajanand Recent Developments/Updates
7.6.6 Sahajanand Competitive Strengths & Weaknesses
7.7 Sino Medical
7.7.1 Sino Medical Details
7.7.2 Sino Medical Major Business
7.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sino Medical Recent Developments/Updates
7.7.6 Sino Medical Competitive Strengths & Weaknesses
7.8 Sorin
7.8.1 Sorin Details
7.8.2 Sorin Major Business
7.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sorin Recent Developments/Updates
7.8.6 Sorin Competitive Strengths & Weaknesses
7.9 Terumo Medical
7.9.1 Terumo Medical Details
7.9.2 Terumo Medical Major Business
7.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Terumo Medical Recent Developments/Updates
7.9.6 Terumo Medical Competitive Strengths & Weaknesses
7.10 Abbott Vascular
7.10.1 Abbott Vascular Details
7.10.2 Abbott Vascular Major Business
7.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Abbott Vascular Recent Developments/Updates
7.10.6 Abbott Vascular Competitive Strengths & Weaknesses
7.11 Advantec Vascular
7.11.1 Advantec Vascular Details
7.11.2 Advantec Vascular Major Business
7.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Advantec Vascular Recent Developments/Updates
7.11.6 Advantec Vascular Competitive Strengths & Weaknesses
7.12 B.Braun Melsengen AG
7.12.1 B.Braun Melsengen AG Details
7.12.2 B.Braun Melsengen AG Major Business
7.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 B.Braun Melsengen AG Recent Developments/Updates
7.12.6 B.Braun Melsengen AG Competitive Strengths & Weaknesses
7.13 Biosensors
7.13.1 Biosensors Details
7.13.2 Biosensors Major Business
7.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biosensors Recent Developments/Updates
7.13.6 Biosensors Competitive Strengths & Weaknesses
7.14 Boston Scientific
7.14.1 Boston Scientific Details
7.14.2 Boston Scientific Major Business
7.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Boston Scientific Recent Developments/Updates
7.14.6 Boston Scientific Competitive Strengths & Weaknesses
7.15 MicroPort Medical
7.15.1 MicroPort Medical Details
7.15.2 MicroPort Medical Major Business
7.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 MicroPort Medical Recent Developments/Updates
7.15.6 MicroPort Medical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cardiovascular Drug-Eluting Stents(DES) Industry Chain
8.2 Cardiovascular Drug-Eluting Stents(DES) Upstream Analysis
8.2.1 Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
8.2.2 Main Manufacturers of Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cardiovascular Drug-Eluting Stents(DES) Production Mode
8.6 Cardiovascular Drug-Eluting Stents(DES) Procurement Model
8.7 Cardiovascular Drug-Eluting Stents(DES) Industry Sales Model and Sales Channels
8.7.1 Cardiovascular Drug-Eluting Stents(DES) Sales Model
8.7.2 Cardiovascular Drug-Eluting Stents(DES) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cardiovascular Drug-Eluting Stents(DES) Introduction
1.2 World Cardiovascular Drug-Eluting Stents(DES) Supply & Forecast
1.2.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value (2018 & 2022 & 2029)
1.2.2 World Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.2.3 World Cardiovascular Drug-Eluting Stents(DES) Pricing Trends (2018-2029)
1.3 World Cardiovascular Drug-Eluting Stents(DES) Production by Region (Based on Production Site)
1.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018-2029)
1.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2018-2029)
1.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2029)
1.3.4 North America Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.5 Europe Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.6 China Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.3.7 Japan Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiovascular Drug-Eluting Stents(DES) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cardiovascular Drug-Eluting Stents(DES) Demand (2018-2029)
2.2 World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region
2.2.1 World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region (2018-2023)
2.2.2 World Cardiovascular Drug-Eluting Stents(DES) Consumption Forecast by Region (2024-2029)
2.3 United States Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.4 China Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.5 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.6 Japan Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.7 South Korea Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.8 ASEAN Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
2.9 India Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029)
3 WORLD CARDIOVASCULAR DRUG-ELUTING STENTS(DES) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Manufacturer (2018-2023)
3.2 World Cardiovascular Drug-Eluting Stents(DES) Production by Manufacturer (2018-2023)
3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023)
3.4 Cardiovascular Drug-Eluting Stents(DES) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiovascular Drug-Eluting Stents(DES) in 2022
3.5.3 Global Concentration Ratios (CR8) for Cardiovascular Drug-Eluting Stents(DES) in 2022
3.6 Cardiovascular Drug-Eluting Stents(DES) Market: Overall Company Footprint Analysis
3.6.1 Cardiovascular Drug-Eluting Stents(DES) Market: Region Footprint
3.6.2 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
3.6.3 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison
4.1.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Comparison
4.2.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison
4.3.1 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
4.5 China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share
4.5.1 China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.5.3 China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
4.6 Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiovascular Drug-Eluting Stents(DES) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Passive Coating
5.2.2 Active Coating
5.3 Market Segment by Type
5.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2018-2029)
5.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2018-2029)
5.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cardiovascular Drug-Eluting Stents(DES) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2018-2029)
6.3.2 World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2018-2029)
6.3.3 World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 MIV Therapeutics
7.1.1 MIV Therapeutics Details
7.1.2 MIV Therapeutics Major Business
7.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 MIV Therapeutics Recent Developments/Updates
7.1.6 MIV Therapeutics Competitive Strengths & Weaknesses
7.2 Orbusneich
7.2.1 Orbusneich Details
7.2.2 Orbusneich Major Business
7.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Orbusneich Recent Developments/Updates
7.2.6 Orbusneich Competitive Strengths & Weaknesses
7.3 Promed Medical
7.3.1 Promed Medical Details
7.3.2 Promed Medical Major Business
7.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Promed Medical Recent Developments/Updates
7.3.6 Promed Medical Competitive Strengths & Weaknesses
7.4 Relisys Medical
7.4.1 Relisys Medical Details
7.4.2 Relisys Medical Major Business
7.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Relisys Medical Recent Developments/Updates
7.4.6 Relisys Medical Competitive Strengths & Weaknesses
7.5 Reva Medical
7.5.1 Reva Medical Details
7.5.2 Reva Medical Major Business
7.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Reva Medical Recent Developments/Updates
7.5.6 Reva Medical Competitive Strengths & Weaknesses
7.6 Sahajanand
7.6.1 Sahajanand Details
7.6.2 Sahajanand Major Business
7.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sahajanand Recent Developments/Updates
7.6.6 Sahajanand Competitive Strengths & Weaknesses
7.7 Sino Medical
7.7.1 Sino Medical Details
7.7.2 Sino Medical Major Business
7.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sino Medical Recent Developments/Updates
7.7.6 Sino Medical Competitive Strengths & Weaknesses
7.8 Sorin
7.8.1 Sorin Details
7.8.2 Sorin Major Business
7.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sorin Recent Developments/Updates
7.8.6 Sorin Competitive Strengths & Weaknesses
7.9 Terumo Medical
7.9.1 Terumo Medical Details
7.9.2 Terumo Medical Major Business
7.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Terumo Medical Recent Developments/Updates
7.9.6 Terumo Medical Competitive Strengths & Weaknesses
7.10 Abbott Vascular
7.10.1 Abbott Vascular Details
7.10.2 Abbott Vascular Major Business
7.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Abbott Vascular Recent Developments/Updates
7.10.6 Abbott Vascular Competitive Strengths & Weaknesses
7.11 Advantec Vascular
7.11.1 Advantec Vascular Details
7.11.2 Advantec Vascular Major Business
7.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Advantec Vascular Recent Developments/Updates
7.11.6 Advantec Vascular Competitive Strengths & Weaknesses
7.12 B.Braun Melsengen AG
7.12.1 B.Braun Melsengen AG Details
7.12.2 B.Braun Melsengen AG Major Business
7.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 B.Braun Melsengen AG Recent Developments/Updates
7.12.6 B.Braun Melsengen AG Competitive Strengths & Weaknesses
7.13 Biosensors
7.13.1 Biosensors Details
7.13.2 Biosensors Major Business
7.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biosensors Recent Developments/Updates
7.13.6 Biosensors Competitive Strengths & Weaknesses
7.14 Boston Scientific
7.14.1 Boston Scientific Details
7.14.2 Boston Scientific Major Business
7.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Boston Scientific Recent Developments/Updates
7.14.6 Boston Scientific Competitive Strengths & Weaknesses
7.15 MicroPort Medical
7.15.1 MicroPort Medical Details
7.15.2 MicroPort Medical Major Business
7.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
7.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 MicroPort Medical Recent Developments/Updates
7.15.6 MicroPort Medical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cardiovascular Drug-Eluting Stents(DES) Industry Chain
8.2 Cardiovascular Drug-Eluting Stents(DES) Upstream Analysis
8.2.1 Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
8.2.2 Main Manufacturers of Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cardiovascular Drug-Eluting Stents(DES) Production Mode
8.6 Cardiovascular Drug-Eluting Stents(DES) Procurement Model
8.7 Cardiovascular Drug-Eluting Stents(DES) Industry Sales Model and Sales Channels
8.7.1 Cardiovascular Drug-Eluting Stents(DES) Sales Model
8.7.2 Cardiovascular Drug-Eluting Stents(DES) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2018-2023)
Table 5. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2024-2029)
Table 6. World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2018-2023) & (K Units)
Table 7. World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2024-2029) & (K Units)
Table 8. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2018-2023)
Table 9. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2024-2029)
Table 10. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cardiovascular Drug-Eluting Stents(DES) Major Market Trends
Table 13. World Cardiovascular Drug-Eluting Stents(DES) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region (2018-2023) & (K Units)
Table 15. World Cardiovascular Drug-Eluting Stents(DES) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cardiovascular Drug-Eluting Stents(DES) Producers in 2022
Table 18. World Cardiovascular Drug-Eluting Stents(DES) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cardiovascular Drug-Eluting Stents(DES) Producers in 2022
Table 20. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cardiovascular Drug-Eluting Stents(DES) Company Evaluation Quadrant
Table 22. World Cardiovascular Drug-Eluting Stents(DES) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
Table 24. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
Table 25. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
Table 26. Cardiovascular Drug-Eluting Stents(DES) Competitive Factors
Table 27. Cardiovascular Drug-Eluting Stents(DES) New Entrant and Capacity Expansion Plans
Table 28. Cardiovascular Drug-Eluting Stents(DES) Mergers & Acquisitions Activity
Table 29. United States VS China Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cardiovascular Drug-Eluting Stents(DES) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 37. China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 42. Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 47. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2018-2023) & (K Units)
Table 49. World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2024-2029) & (K Units)
Table 50. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2018-2023) & (K Units)
Table 56. World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2024-2029) & (K Units)
Table 57. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. MIV Therapeutics Major Business
Table 63. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 64. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. MIV Therapeutics Recent Developments/Updates
Table 66. MIV Therapeutics Competitive Strengths & Weaknesses
Table 67. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 68. Orbusneich Major Business
Table 69. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 70. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Orbusneich Recent Developments/Updates
Table 72. Orbusneich Competitive Strengths & Weaknesses
Table 73. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 74. Promed Medical Major Business
Table 75. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 76. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Promed Medical Recent Developments/Updates
Table 78. Promed Medical Competitive Strengths & Weaknesses
Table 79. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 80. Relisys Medical Major Business
Table 81. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 82. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Relisys Medical Recent Developments/Updates
Table 84. Relisys Medical Competitive Strengths & Weaknesses
Table 85. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 86. Reva Medical Major Business
Table 87. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 88. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Reva Medical Recent Developments/Updates
Table 90. Reva Medical Competitive Strengths & Weaknesses
Table 91. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 92. Sahajanand Major Business
Table 93. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 94. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sahajanand Recent Developments/Updates
Table 96. Sahajanand Competitive Strengths & Weaknesses
Table 97. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 98. Sino Medical Major Business
Table 99. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 100. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sino Medical Recent Developments/Updates
Table 102. Sino Medical Competitive Strengths & Weaknesses
Table 103. Sorin Basic Information, Manufacturing Base and Competitors
Table 104. Sorin Major Business
Table 105. Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 106. Sorin Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sorin Recent Developments/Updates
Table 108. Sorin Competitive Strengths & Weaknesses
Table 109. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 110. Terumo Medical Major Business
Table 111. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 112. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Terumo Medical Recent Developments/Updates
Table 114. Terumo Medical Competitive Strengths & Weaknesses
Table 115. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 116. Abbott Vascular Major Business
Table 117. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 118. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Abbott Vascular Recent Developments/Updates
Table 120. Abbott Vascular Competitive Strengths & Weaknesses
Table 121. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 122. Advantec Vascular Major Business
Table 123. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 124. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Advantec Vascular Recent Developments/Updates
Table 126. Advantec Vascular Competitive Strengths & Weaknesses
Table 127. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 128. B.Braun Melsengen AG Major Business
Table 129. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 130. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. B.Braun Melsengen AG Recent Developments/Updates
Table 132. B.Braun Melsengen AG Competitive Strengths & Weaknesses
Table 133. Biosensors Basic Information, Manufacturing Base and Competitors
Table 134. Biosensors Major Business
Table 135. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 136. Biosensors Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Biosensors Recent Developments/Updates
Table 138. Biosensors Competitive Strengths & Weaknesses
Table 139. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 140. Boston Scientific Major Business
Table 141. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 142. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Boston Scientific Recent Developments/Updates
Table 144. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 145. MicroPort Medical Major Business
Table 146. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 147. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Cardiovascular Drug-Eluting Stents(DES) Upstream (Raw Materials)
Table 149. Cardiovascular Drug-Eluting Stents(DES) Typical Customers
Table 150. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
Table 1. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2018-2023)
Table 5. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2024-2029)
Table 6. World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2018-2023) & (K Units)
Table 7. World Cardiovascular Drug-Eluting Stents(DES) Production by Region (2024-2029) & (K Units)
Table 8. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2018-2023)
Table 9. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2024-2029)
Table 10. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cardiovascular Drug-Eluting Stents(DES) Major Market Trends
Table 13. World Cardiovascular Drug-Eluting Stents(DES) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cardiovascular Drug-Eluting Stents(DES) Consumption by Region (2018-2023) & (K Units)
Table 15. World Cardiovascular Drug-Eluting Stents(DES) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cardiovascular Drug-Eluting Stents(DES) Producers in 2022
Table 18. World Cardiovascular Drug-Eluting Stents(DES) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cardiovascular Drug-Eluting Stents(DES) Producers in 2022
Table 20. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cardiovascular Drug-Eluting Stents(DES) Company Evaluation Quadrant
Table 22. World Cardiovascular Drug-Eluting Stents(DES) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
Table 24. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
Table 25. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
Table 26. Cardiovascular Drug-Eluting Stents(DES) Competitive Factors
Table 27. Cardiovascular Drug-Eluting Stents(DES) New Entrant and Capacity Expansion Plans
Table 28. Cardiovascular Drug-Eluting Stents(DES) Mergers & Acquisitions Activity
Table 29. United States VS China Cardiovascular Drug-Eluting Stents(DES) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cardiovascular Drug-Eluting Stents(DES) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cardiovascular Drug-Eluting Stents(DES) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 37. China Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 42. Rest of World Based Cardiovascular Drug-Eluting Stents(DES) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share (2018-2023)
Table 47. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2018-2023) & (K Units)
Table 49. World Cardiovascular Drug-Eluting Stents(DES) Production by Type (2024-2029) & (K Units)
Table 50. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2018-2023) & (K Units)
Table 56. World Cardiovascular Drug-Eluting Stents(DES) Production by Application (2024-2029) & (K Units)
Table 57. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. MIV Therapeutics Major Business
Table 63. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 64. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. MIV Therapeutics Recent Developments/Updates
Table 66. MIV Therapeutics Competitive Strengths & Weaknesses
Table 67. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 68. Orbusneich Major Business
Table 69. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 70. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Orbusneich Recent Developments/Updates
Table 72. Orbusneich Competitive Strengths & Weaknesses
Table 73. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 74. Promed Medical Major Business
Table 75. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 76. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Promed Medical Recent Developments/Updates
Table 78. Promed Medical Competitive Strengths & Weaknesses
Table 79. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 80. Relisys Medical Major Business
Table 81. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 82. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Relisys Medical Recent Developments/Updates
Table 84. Relisys Medical Competitive Strengths & Weaknesses
Table 85. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 86. Reva Medical Major Business
Table 87. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 88. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Reva Medical Recent Developments/Updates
Table 90. Reva Medical Competitive Strengths & Weaknesses
Table 91. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 92. Sahajanand Major Business
Table 93. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 94. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sahajanand Recent Developments/Updates
Table 96. Sahajanand Competitive Strengths & Weaknesses
Table 97. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 98. Sino Medical Major Business
Table 99. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 100. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sino Medical Recent Developments/Updates
Table 102. Sino Medical Competitive Strengths & Weaknesses
Table 103. Sorin Basic Information, Manufacturing Base and Competitors
Table 104. Sorin Major Business
Table 105. Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 106. Sorin Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sorin Recent Developments/Updates
Table 108. Sorin Competitive Strengths & Weaknesses
Table 109. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 110. Terumo Medical Major Business
Table 111. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 112. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Terumo Medical Recent Developments/Updates
Table 114. Terumo Medical Competitive Strengths & Weaknesses
Table 115. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 116. Abbott Vascular Major Business
Table 117. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 118. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Abbott Vascular Recent Developments/Updates
Table 120. Abbott Vascular Competitive Strengths & Weaknesses
Table 121. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 122. Advantec Vascular Major Business
Table 123. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 124. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Advantec Vascular Recent Developments/Updates
Table 126. Advantec Vascular Competitive Strengths & Weaknesses
Table 127. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 128. B.Braun Melsengen AG Major Business
Table 129. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 130. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. B.Braun Melsengen AG Recent Developments/Updates
Table 132. B.Braun Melsengen AG Competitive Strengths & Weaknesses
Table 133. Biosensors Basic Information, Manufacturing Base and Competitors
Table 134. Biosensors Major Business
Table 135. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 136. Biosensors Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Biosensors Recent Developments/Updates
Table 138. Biosensors Competitive Strengths & Weaknesses
Table 139. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 140. Boston Scientific Major Business
Table 141. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 142. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Boston Scientific Recent Developments/Updates
Table 144. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 145. MicroPort Medical Major Business
Table 146. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 147. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Cardiovascular Drug-Eluting Stents(DES) Upstream (Raw Materials)
Table 149. Cardiovascular Drug-Eluting Stents(DES) Typical Customers
Table 150. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
LIST OF FIGURES
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture
Figure 2. World Cardiovascular Drug-Eluting Stents(DES) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cardiovascular Drug-Eluting Stents(DES) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 5. World Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2018-2029)
Figure 7. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2018-2029)
Figure 8. North America Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 9. Europe Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 10. China Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 11. Japan Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 12. Cardiovascular Drug-Eluting Stents(DES) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 15. World Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share by Region (2018-2029)
Figure 16. United States Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 17. China Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 18. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 19. Japan Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 22. India Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiovascular Drug-Eluting Stents(DES) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiovascular Drug-Eluting Stents(DES) Markets in 2022
Figure 26. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 30. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 32. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Type in 2022
Figure 34. Passive Coating
Figure 35. Active Coating
Figure 36. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Type (2018-2029)
Figure 37. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Type (2018-2029)
Figure 38. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Application (2018-2029)
Figure 44. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Application (2018-2029)
Figure 45. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Cardiovascular Drug-Eluting Stents(DES) Industry Chain
Figure 47. Cardiovascular Drug-Eluting Stents(DES) Procurement Model
Figure 48. Cardiovascular Drug-Eluting Stents(DES) Sales Model
Figure 49. Cardiovascular Drug-Eluting Stents(DES) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture
Figure 2. World Cardiovascular Drug-Eluting Stents(DES) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cardiovascular Drug-Eluting Stents(DES) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 5. World Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Region (2018-2029)
Figure 7. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Region (2018-2029)
Figure 8. North America Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 9. Europe Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 10. China Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 11. Japan Cardiovascular Drug-Eluting Stents(DES) Production (2018-2029) & (K Units)
Figure 12. Cardiovascular Drug-Eluting Stents(DES) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 15. World Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share by Region (2018-2029)
Figure 16. United States Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 17. China Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 18. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 19. Japan Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 22. India Cardiovascular Drug-Eluting Stents(DES) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiovascular Drug-Eluting Stents(DES) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiovascular Drug-Eluting Stents(DES) Markets in 2022
Figure 26. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cardiovascular Drug-Eluting Stents(DES) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 30. China Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cardiovascular Drug-Eluting Stents(DES) Production Market Share 2022
Figure 32. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Type in 2022
Figure 34. Passive Coating
Figure 35. Active Coating
Figure 36. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Type (2018-2029)
Figure 37. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Type (2018-2029)
Figure 38. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Cardiovascular Drug-Eluting Stents(DES) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Cardiovascular Drug-Eluting Stents(DES) Production Market Share by Application (2018-2029)
Figure 44. World Cardiovascular Drug-Eluting Stents(DES) Production Value Market Share by Application (2018-2029)
Figure 45. World Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Cardiovascular Drug-Eluting Stents(DES) Industry Chain
Figure 47. Cardiovascular Drug-Eluting Stents(DES) Procurement Model
Figure 48. Cardiovascular Drug-Eluting Stents(DES) Sales Model
Figure 49. Cardiovascular Drug-Eluting Stents(DES) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
